STAT

STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watching

STAT+: AstraZeneca and Ionis detail surprise failure of heart disease drug, with Alnylam closely watchingWorldPing

Roivant's autoimmune drug approval, Cytokinetics reports full data for heart condition treatment, and more biotech news…

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news

Sweetener used in chewing gum and jam linked to strokes and heart attacksWorldPing
The Guardian

Sweetener used in chewing gum and jam linked to strokes and heart attacks

High blood levels of xylitol associated with higher risk of major cardiovascular events, in largest study of its kind A common sweetener used in products such as chewing gum, toothpaste, jam, yoghurts and ice-cream has been linked to an increased ris…

Brief by WorldPing · Original reporting by The Guardian